Chapter IX
Sequelae of cerebrovascular disease - I69

Note:

This category is to be used to indicate conditions in I60-I67 as the cause of sequelae, themselves classified elsewhere. The "sequelae" include conditions specified as such or as late effects, or those present one year or more after onset of the causal condition.

I69.0

Sequelae of subarachnoid haemorrhage

I69.1

Sequelae of intracerebral haemorrhage

I69.2

Sequelae of other nontraumatic intracranial haemorrhage

I69.3

Sequelae of cerebral infarction

I69.4

Sequelae of stroke, not specified as haemorrhage or infarction

I69.8

Sequelae of other and unspecified cerebrovascular diseases

Related drugs:

• Alpha-Dihydroergocryptine; Caffeine
• Bencyclane
• Cinnarizine
• Cinnarizine; Piracetam
• Ginkgo Biloba
• Etamivan; Etofylline; Hexobendine
• Nicergoline
• Nimodipine
• Piracetam
• Pyritinol
• Tolperisone
• Vinpocetine

The information was verified by Dr. Rachana Salvi, MD Pharmacology